Stockscreener 앱 받기
0.4193
12.39%
-0.0593
시간 외 거래:
.41
-0.0093
-2.22%
전일 마감가:
$0.4786
열려 있는:
$0.4695
하루 거래량:
1.20M
Relative Volume:
2.08
시가총액:
$2.46M
수익:
-
순이익/손실:
$-8.26M
주가수익비율:
-0.00782
EPS:
-53.609
순현금흐름:
$-12.17M
1주 성능:
-65.35%
1개월 성능:
-73.79%
6개월 성능:
-69.17%
1년 성능:
-96.84%
1일 변동 폭
$0.395
$0.472
1주일 범위
$0.395
$0.693
52주 변동 폭
$0.395
$15.64
Gri Bio Inc Stock (GRI) Company Profile
명칭
Gri Bio Inc
전화
(619) 400-1171
주소
2223 AVENIDA DE LA PLAYA, LA JOLLA
GRI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GRI
Gri Bio Inc
|
0.4193 | 2.81M | 0 | -8.26M | -12.17M | -53.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.52 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.79 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
862.05 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.10 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.46 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gri Bio Inc Stock (GRI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-09 | 개시 | H.C. Wainwright | Buy |
Gri Bio Inc 주식(GRI)의 최신 뉴스
GRI Bio closes $8 million public offering of common stock and warrants - Investing.com Nigeria
GRI Bio closes $8 million public offering of common stock and warrants By Investing.com - Investing.com South Africa
GRI Bio (NASDAQ: GRI) closes $8.0M offering of 10,666,667 shares, warrants - Stock Titan
GRI Bio Launches $6.7 Million Public Offering - TipRanks
GRI Bio prices $8 million public offering at $0.75 per share - Investing.com
GRI Bio announces pricing of $8M public offering - MSN
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
GRI Bio (NASDAQ: GRI) prices $8,000,000 offering of 10,666,667 shares at $0.75 - Stock Titan
What's Going On With GRI Bio Stock Thursday?GRI Bio (NASDAQ:GRI) - Benzinga
GRI Bio’s tazarotene achieves Phase IIa IPF success - Yahoo
GRI Bio’s IPF drug shows positive Phase 2a results with improved lung function - Investing.com Nigeria
GRI Bio Meets Key Goals In Phase 2 Trial Of GRI-0621 For Idiopathic Pulmonary Fibrosis - Nasdaq
GRI Bio Announces Positive Phase 2a Trial Results - TipRanks
GRI Bio, Inc. Announces Positive Phase 2a Trial Results for GRI-0621 - TradingView
GRI Bio Announces Positive Topline Data from its Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”) - GlobeNewswire
A new trading data show Milestone Pharmaceuticals Inc (MIST) is showing positive returns. - Setenews
Financial Contrast: CalciMedica (NASDAQ:CALC) and GRI Bio (NASDAQ:GRI) - Defense World
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.45% - Investing.com UK
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.45% - Investing.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
GRI Bio Reports Positive Phase 2a Trial Results - TipRanks
GRI Bio Increceives topline data from phase 2a trial for idiopathic pulmonary fibrosisSEC filing - marketscreener.com
GRI Bio Reports Positive Phase 2a Trial Results for IPF Treatment - TradingView
Ascendiant Capital Maintains GRI Bio (GRI) Buy Recommendation - Nasdaq
Ascendiant Capital Raises Price Target for GRI to $36.00 | GRI S - GuruFocus
GRI Bio reports positive phase 2a trial results - MSN
Why GRI Bio Inc. stock is seen as undervaluedSell Signal & Weekly Return Optimization Alerts - Newser
JTC Team Companies to Present in Webull Corporate Connect Webinar Series: Biotech/MedTech on August 19-21, 2025 - The Herald-Mail
GRI Bio receives Nasdaq notice for non-compliance with equity listing rule - Investing.com Australia
GRI Bio (GRI) Stock Analysis Report | Financials & Insights - Benzinga
GRI Bio Inc. (GRI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What insider trading reveals about GRI Bio Inc. stockWeekly Gains Summary & Long-Term Safe Investment Ideas - BỘ NỘI VỤ
Stop Loss: What sentiment indicators say about GRI Bio Inc. stock2025 Retail Activity & Long-Term Growth Portfolio Plans - moha.gov.vn
Buy Signal: What insider trading reveals about GRI Bio Inc. stock2025 Technical Overview & Low Risk Profit Maximizing Plans - moha.gov.vn
This trade activity should not be overlooked: GRI Bio Inc (GRI) - Setenews
Wall Street analysts’ outlook for Moolec Science SA (MLEC) - Setenews
A better buy-in window may exist right now for Movano Inc (MOVE) - Setenews
GRI Bio Inc Stock Analysis and ForecastRisk Mitigation Techniques & Rapid Capital Appreciation - earlytimes.in
GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ('IPF') - ADVFN
GRI Stock Price and Chart — NASDAQ:GRI - TradingView
The growth track for GRI Bio Inc (GRI) has changed recently - Setenews
What technical charts say about GRI Bio Inc. stock2025 Price Action Summary & Weekly Setup with High ROI Potential - newser.com
How GRI Bio Inc. stock benefits from strong dollarShare Buyback & Free Daily Entry Point Trade Alerts - newser.com
GRI Bio Inc. stock daily chart insightsWeekly Investment Report & Low Drawdown Momentum Ideas - newser.com
Visual analytics tools that track GRI Bio Inc. performanceBond Market & Reliable Price Breakout Signals - newser.com
How supply chain issues affect GRI Bio Inc. stock2025 Top Decliners & Daily Profit Focused Screening - newser.com
Gri Bio Inc (GRI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.18%
0.62%
자본화:
|
볼륨(24시간):